← Browse by Condition
Medical Condition
age related macular degeneration
Total Trials
8
Recruiting Now
8
Trial Phases
Phase 1, Phase 2
ClinicalMetric tracks all active clinical trials for age related macular degeneration sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.
Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.
Frequently Asked Questions — age related macular degeneration Clinical Trials
How many clinical trials are currently recruiting for age related macular degeneration?
ClinicalMetric currently tracks 8 actively recruiting clinical trials for age related macular degeneration, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 8. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for age related macular degeneration?
age related macular degeneration research spans Phase 1 (3 trials), Phase 2 (3 trials). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a age related macular degeneration clinical trial?
Eligibility criteria for age related macular degeneration trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Trial Phases
Phase 1 3
Phase 2 3
Top Sponsors
1 trial
1 trial
1 trial
1 trial
1 trial
Recruiting Clinical Trials
NCT05465252
Recruiting
Enrollment
24 pts
Location
China
Sponsor
Shanghai General Hospital, Sha...
NCT06087458 Phase 1, Phase 2
Recruiting
Enrollment
60 pts
Location
United States, Austr...
Sponsor
Perceive Biotherapeutics, Inc.
NCT03848663
Recruiting
Enrollment
108 pts
Location
United States
Sponsor
University of Minnesota
NCT05355415
Recruiting
Enrollment
100 pts
Location
United States
Sponsor
Food and Drug Administration (...
NCT01496625
Recruiting
Enrollment
650 pts
Location
United States
Sponsor
National Eye Institute (NEI)
NCT07160179 Phase 1, Phase 2
Recruiting
Enrollment
66 pts
Location
United States
Sponsor
AbbVie
NCT07002372
Recruiting
Enrollment
182 pts
Location
China
Sponsor
Second Affiliated Hospital, Sc...
NCT06458595 Phase 1, Phase 2
Recruiting
Enrollment
44 pts
Location
China
Sponsor
Chengdu Origen Biotechnology C...
Related Conditions
geographic atrophy (2) diabetic retinopathy (2) retinal vein occlusion (2) non neovascular amd (1) retinal degeneration (1) retinitis pigmentosa (1) hydroxychloroquine retinopathy (1) usher syndromes (1) late onset retinal degeneration (1) cone dystrophy (1) cone rod dystrophy (1) rod cone dystrophy (1)
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: July 2026 · Data Methodology